JCO Oncology Practice (@jcoop_asco) 's Twitter Profile
JCO Oncology Practice

@jcoop_asco

Impactful information & insights to changes & challenges inherent in delivering equitable, high-quality oncology care. Part of @JCO_ASCO family of journals.

ID: 4854832205

linkhttp://ascopubs.org/journal/op calendar_today27-01-2016 20:43:54

2,2K Tweet

14,14K Takipçi

331 Takip Edilen

JCO Oncology Practice (@jcoop_asco) 's Twitter Profile Photo

Electronic Patient-Reported Outcome-Driven Symptom Management by Oncology Pharmacists in a Majority-Minority Population: An Implementation Study ➡️ brnw.ch/21wLw1P Alex Chan, PharmD, MPH #PharmOnc

JCO Oncology Practice (@jcoop_asco) 's Twitter Profile Photo

Integration of Germline Genetic Testing Into Routine Clinical Practice for Patients With #PancreaticAdenocarcinoma ➡️ brnw.ch/21wLyl1 #gicsm

JCO Oncology Practice (@jcoop_asco) 's Twitter Profile Photo

Read about Outcomes of Patients With Newly Diagnosed #AML and Hyperleukocytosis: ascopubs.org/doi/abs/10.120… #leusm @Fadihaddad_MD

JCO Oncology Practice (@jcoop_asco) 's Twitter Profile Photo

Subcutaneous vs Intravenous Trastuzumab/Pertuzumab: A Time and Motion Substudy of a Phase II Trial of Adjuvant Trastuzumab/Pertuzumab for Stage I HER21 #BreastCancer (ADEPT Trial) ➡️brnw.ch/21wLBo9 Ada Waks #bcsm

JCO Oncology Practice (@jcoop_asco) 's Twitter Profile Photo

Evolving Practices in Immune-Related Adverse Event Management: Insights From the IMMUCARE Multidisciplinary Board brnw.ch/21wLCEB

JCO Oncology Practice (@jcoop_asco) 's Twitter Profile Photo

Real-World Noninferiority Assessment of Two Filgrastim Biosimilars in Patients Receiving Myelosuppressive #Chemotherapy: brnw.ch/21wLEa4 #RWE

JCO Oncology Practice (@jcoop_asco) 's Twitter Profile Photo

Risk Without Reward: Differing Patterns of #Chemotherapy Use Do Not Improve Outcomes in Stage II Early-Onset #ColonCancer: brnw.ch/21wLHNJ #crcsm

JCO Oncology Practice (@jcoop_asco) 's Twitter Profile Photo

Exploring the Relationship Among Financial Hardship, Anxiety, and Depression in Patients With Cancer: A Longitudinal Study brnw.ch/21wM03L Betina Yanez #FinancialToxicity

JCO Oncology Practice (@jcoop_asco) 's Twitter Profile Photo

Effects of Adjuvant Endocrine Therapy–Specific Perceptions on Response to a Behavioral Intervention for Adjuvant Endocrine Therapy Adherence in Patients With #BreastCancer: brnw.ch/21wM1PO Kelcie D. Willis, Ph.D. MGH Psychiatry #bcsm

JCO Oncology Practice (@jcoop_asco) 's Twitter Profile Photo

Selecting Immune Checkpoint Inhibitor Side Effects for Real-Time Monitoring in Routine Cancer Care: A Modified Delphi Study brnw.ch/21wM5gd @julialaikwon @m_jefford Claudia Rutherford Stephanie Best #ICI

JCO Oncology Practice (@jcoop_asco) 's Twitter Profile Photo

Under-Representation and Under-Reporting of Minoritized Racial and Ethnic Groups in #ClinicalTrials on Immune Checkpoint Inhibitors: brnw.ch/21wMbc6 Alfredo Chua #ICI

JCO Oncology Practice (@jcoop_asco) 's Twitter Profile Photo

Now available: new ASCO guideline clinical insights on targeted therapies, sequencing strategies, and beyond in metastatic hormone-receptor positive #BreastCancer: brnw.ch/21wMbqE #bcsm #JCOOP

JCO Oncology Practice (@jcoop_asco) 's Twitter Profile Photo

Integrating Family Caregivers Into #CancerCare: Implementation of Evidence-Based Caregiver Protocols Into #GynecologicOncology Practice brnw.ch/21wMd3w Dr. Heidi Donovan #gynonc

JCO Oncology Practice (@jcoop_asco) 's Twitter Profile Photo

Association of Community-Level Social Vulnerability With #ClinicalTrial Discussion and Participation Among Cancer Survivors: brnw.ch/21wMlQ2 Rishi Sekar #SurvOnc